Evidence map›Paper›PMID 29442231›Full record

ArticleEuropean child & adolescent psychiatry2018

A cost-effectiveness analysis of school-based suicide prevention programmes.

Susan Ahern, Lee-Ann Burke, Brendan McElroy, Paul Corcoran, Elaine M McMahon, Helen Keeley, Vladimir Carli, Camilla Wasserman, Christina W Hoven, Marco Sarchiapone and 14 more

Abstract read
PubMed Publisher
In one paragraph

Article in European child & adolescent psychiatry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Susan AhernCentre for Policy Studies, Cork University Business School, University College Cork, Cork, Ireland. susan.ahern@ucc.ie.
Lee-Ann BurkeCork University Business School, University College Cork, Cork, Ireland.
Brendan McElroyCork University Business School, University College Cork, Cork, Ireland.
Paul CorcoranNational Suicide Research Foundation, Cork, Ireland.
Elaine M McMahonNational Suicide Research Foundation, Cork, Ireland.
Helen KeeleyChild and Adolescent Mental Health Service, Health Service Executive, Mallow, Cork, Ireland.
Vladimir CarliNational Centre for Suicide Research and Prevention of Mental Ill-Health (NASP), Karolinska Institutet, Stockholm, Sweden.
Camilla WassermanNational Centre for Suicide Research and Prevention of Mental Ill-Health (NASP), Karolinska Institutet, Stockholm, Sweden.
Christina W HovenDepartment of Child and Adolescent Psychiatry, New York State Psychiatric Institute, Columbia University, New York, NY, USA.
Marco SarchiaponeDepartment of Medicine and Health Science, University of Molise, Campobasso, Italy.
Alan ApterSchneider Children's Medical Centre of Israel, Tel-Aviv University, Tel Aviv, Israel.
Judit BalazsInstitute of Psychology, Eötvös Loránd University, Budapest, Hungary.
Raphaela BanzerAddiction Help Services B.I.N., Anichstraße 34, Innsbruck, Austria.
Julio BobesUniversity of Oviedo, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Oviedo, Spain.
Romuald BrunnerDepartment of Child and Adolescent Psychiatry, Centre for Psychosocial Medicine, University of Heidelberg, Heidelberg, Germany.
Doina CosmanClinical Psychology Department, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Christian HaringAddiction Help Services B.I.N., Anichstraße 34, Innsbruck, Austria.
Michael KaessDepartment of Child and Adolescent Psychiatry, Centre for Psychosocial Medicine, University of Heidelberg, Heidelberg, Germany.
Jean-Pierre KahnDepartment of Psychiatry, CHRU de NANCY and Pole 6, Centre Psychothérapique de Nancy, Université de Lorraine, Nancy, France.
Agnes KeresztenyInstitute of Psychology, Eötvös Loránd University, Budapest, Hungary.
Vita PostuvanSlovene Centre for Suicide Research, Andrej Marusic Institute, University of Primorska, Koper, Slovenia.
Pilar A SáizUniversity of Oviedo, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Oviedo, Spain.
Peeter VarnikEstonian-Swedish Mental Health and Suicidology Institute, Tallinn, Estonia.
Danuta WassermanNational Centre for Suicide Research and Prevention of Mental Ill-Health (NASP), Karolinska Institutet, Stockholm, Sweden.

Funding

Coordination Theme 1 (Health) of the European Union Seventh Framework Programme (FP7) HEALTH-F2-2009-223091
6 · The paper itself

Abstract

Suicide is one of the leading causes of death among young people globally. In light of emerging evidence supporting the effectiveness of school-based suicide prevention programmes, an analysis of cost-effectiveness is required. We aimed to conduct a full cost-effectiveness analysis (CEA) of the large pan-European school-based RCT, Saving and Empowering Young Lives in Europe (SEYLE). The health outcomes of interest were suicide attempt and severe suicidal ideation with suicide plans. Adopting a payer's perspective, three suicide prevention interventions were modelled with a Control over a 12-month time period. Incremental cost-effectiveness ratios (ICERs) indicate that the Youth Aware of Mental Health (YAM) programme has the lowest incremental cost per 1% point reduction in incident for both outcomes and per quality adjusted life year (QALY) gained versus the Control. The ICERs reported for YAM were €34.83 and €45.42 per 1% point reduction in incident suicide attempt and incident severe suicidal ideation, respectively, and a cost per QALY gained of €47,017 for suicide attempt and €48,216 for severe suicidal ideation. Cost-effectiveness acceptability curves were used to examine uncertainty in the QALY analysis, where cost-effectiveness probabilities were calculated using net monetary benefit analysis incorporating a two-stage bootstrapping technique. For suicide attempt, the probability that YAM was cost-effective at a willingness to pay of €47,000 was 39%. For severe suicidal ideation, the probability that YAM was cost-effective at a willingness to pay of €48,000 was 43%. This CEA supports YAM as the most cost-effective of the SEYLE interventions in preventing both a suicide attempt and severe suicidal ideation.Trial registration number DRKS00000214.

Indexed as

Suicidal IdeationAdolescentCost-Benefit AnalysisFemaleHumansMaleSchool Health ServicesSuicide, AttemptedAdolescentsCost-effectivenessInterventionPreventionSchoolSuicidal ideationSuicide attempt

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.